These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9312461)

  • 21. Genetic factors predicting response to interferon treatment for viral hepatitis C.
    Stärkel P
    Gut; 2008 Apr; 57(4):440-2. PubMed ID: 18334658
    [No Abstract]   [Full Text] [Related]  

  • 22. A la carte interferon for hepatitis C?
    Marcellin P; Benhamou JP; Heathcote J; Bismuth H; Desmet V; Guardia J; Lok A; Buschenfeld KH; Pagliaro L; Paumgartner G; Rodes J; Sherlock S
    Hepatology; 2000 Sep; 32(3):678-9. PubMed ID: 10991636
    [No Abstract]   [Full Text] [Related]  

  • 23. [Features and therapy of the patients with chronic hepatitis C resistant to IFN therapy].
    Imazeki F; Yokosuka O; Omata M
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):1017-21. PubMed ID: 7563659
    [No Abstract]   [Full Text] [Related]  

  • 24. Combination of interferon and ribavirin in chronic hepatitis C: re-treatment of nonresponders to interferon.
    Di Bisceglie AM; Thompson J; Smith-Wilkaitis N; Brunt EM; Bacon BR
    Hepatology; 2001 Mar; 33(3):704-7. PubMed ID: 11230751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon therapy in chronic viral hepatitis.
    Guptan RC; Sarin SK
    J Assoc Physicians India; 1995; Suppl 3():44-51. PubMed ID: 8773122
    [No Abstract]   [Full Text] [Related]  

  • 26. Mechanism of action of interferon and ribavirin in treatment of hepatitis C.
    Feld JJ; Hoofnagle JH
    Nature; 2005 Aug; 436(7053):967-72. PubMed ID: 16107837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strategies for hepatitis C therapeutic intervention: now and next.
    Tan SL; He Y; Huang Y; Gale M
    Curr Opin Pharmacol; 2004 Oct; 4(5):465-70. PubMed ID: 15351350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obesity and its nurturing effect on hepatitis C.
    McCullough AJ
    Hepatology; 2003 Sep; 38(3):557-9. PubMed ID: 12939581
    [No Abstract]   [Full Text] [Related]  

  • 29. Therapy of acute hepatitis C.
    Alberti A; Boccato S; Vario A; Benvegnù L
    Hepatology; 2002 Nov; 36(5 Suppl 1):S195-200. PubMed ID: 12407594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The interferon sensitivity determining region: all hepatitis C virus isolates are not the same.
    Herion D; Hoofnagle JH
    Hepatology; 1997 Mar; 25(3):769-71. PubMed ID: 9049233
    [No Abstract]   [Full Text] [Related]  

  • 31. [Interferon therapy in chronic active viral hepatitis].
    Lengyel G; Fehér J
    Orv Hetil; 1995 Jan; 136(1):3-7. PubMed ID: 7531317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of acute hepatitis C].
    García Compeán D
    Rev Gastroenterol Mex; 2002 Oct; 67 Suppl 2():S61-6. PubMed ID: 12712857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hepatitis C: update].
    Hügle T; Cerny A
    Dtsch Med Wochenschr; 2003 Sep; 128(38):1963-8. PubMed ID: 14502449
    [No Abstract]   [Full Text] [Related]  

  • 34. Hepatitis C: treatment challenges.
    Copley L
    Prof Nurse; 2003 Nov; 19(3):133-4. PubMed ID: 14639900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon therapy in hepatitis C virus (HCV) induced chronic hepatitis: clinical significance of pretreatment with glycyrhizine.
    Fujisawa K
    Trop Gastroenterol; 1991; 12(4):176-9. PubMed ID: 1726032
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hepatitis C and drug use: epidemiology, screening, natural history and treatment].
    Lucidarme D
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B112-20. PubMed ID: 12180278
    [No Abstract]   [Full Text] [Related]  

  • 37. Effectiveness of interferon plus ribavirin combination in the treatment of naive patients with hepatitis C virus type 5. A French multicentre retrospective study.
    Bonny C; Fontaine H; Poynard T; Hézode C; Larrey D; Marcellin P; Bourlière M; Bronowicki JP; Merle P; Zarski JP; Sapey T; Guillemard C; Ughetto S; Henquell C; Nicolas C; Roche C; Randl K; Bommelaer G; Abergel A
    Aliment Pharmacol Ther; 2006 Aug; 24(4):593-600. PubMed ID: 16907892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Optimal antiviral therapy of chronic hepatitis caused by hepatitis C virus].
    Cooreman MP; Stadhouders P
    Orv Hetil; 1997 Jun; 138(22 Suppl 1):1476-82. PubMed ID: 9221377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New therapeutic strategies for hepatitis C.
    Di Bisceglie AM; McHutchison J; Rice CM
    Hepatology; 2002 Jan; 35(1):224-31. PubMed ID: 11786980
    [No Abstract]   [Full Text] [Related]  

  • 40. [The role of interferon in the treatment of viral hepatitis and its perspective].
    Zhang DF
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jan; 19(1):2-4. PubMed ID: 21272448
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.